GA
ABBV icon

Guerra Advisors’s AbbVie ABBV Stock Holding History

Guerra Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.49M Buy
15,071
+4,678
+45% +$953K 1.29% 26
2025
Q2 		$1.93M Buy
10,393
+1,884
+22% +$350K 0.91% 36
2025
Q1 		$1.78M Buy
8,509
+70
+0.8% +$13.6K 1% 32
2024
Q4 		$1.5M Buy
+8,439
New +$1.55M 0.83% 27

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guerra Advisors's ABBV Position: Q3 2025 in Review

Guerra Advisors increased its AbbVie (ABBV) stake by 45% in Q3 2025, buying an estimated $953K and bringing the position to 15,071 shares worth $3.49M. The position accounts for 1.29% of the portfolio, ranked #26.

Guerra Advisors first reported a position in ABBV in Q4 2024 and has held it in 4 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Guerra Advisors held 15,071 shares of AbbVie worth $3.49M as of Q3 2025.
  • Guerra Advisors bought 4,678 AbbVie shares in Q3 2025, an estimated $953K.
  • AbbVie made up 1.29% of Guerra Advisors's portfolio in Q3 2025, its #26 holding.
  • Guerra Advisors first reported a position in AbbVie in Q4 2024 and has held it in 4 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.